Philippe Nore

Philippe Nore is an accomplished executive with extensive experience in commercial strategy and leadership within the biotechnology and medical technology sectors. Currently serving as a Board Member at PharmaNest, Nore advises on product and commercial strategy for Digital Pathology AI biomarkers. As Chief Commercial Officer at 4G Clinical, Nore leads global commercial operations and strategy for a clinical trial software provider. Prior roles include Vice President at Adaptive Biotechnologies, where Nore managed business development and global commercialization of innovative diagnostic products, and Co-founder and CEO of MiNDERA Dx, a MedTech firm focused on advanced skin diagnostics. Nore has also held senior positions at Roche, Ventana Medical Systems, and Bain & Co., developing strategic initiatives and partnerships across various healthcare markets. Nore holds an MBA in Finance from The Wharton School and an MSc in Chemical Engineering from ESPCI Paris - PSL.